Eli Lilly and Company
$1,373.29
+84.99 · +6.60% today
Market open · updated 12:44:26 PM ET
- High
- $1,312.68 8:00 PM
- Low
- $1,267.12 7:05 AM
Against the S&P 500 Price change through Oct 28, 2026
LLY+19.88%
S&P 500+13.26%
LLY+57.09%
S&P 500+12.41%
LLY+129.96%
S&P 500+88.06%
LLY+408.51%
S&P 500+68.51%
Key numbers
- Previous close
- $1,288.30
- Open
- $1,332.73
- Day's range
- $1,330.00 – $1,408.38
- 52-week range
- $812.25 – $1,408.38
- Volume
- 2.6 million
- Average volume
- 2.6 million
- Market value
- $1.29 trillion
- Price to earnings
- 43.1last 12 months
- Earnings per share
- $29.93last 12 months
- Beta
- 0.45moves less than the market
- Dividend
- $6.69 a year · 0.52%
- 50-day average
- $1,191.81
- 200-day average
- $1,088.04
Thursday, Oct 29, 2026, before the open.
Analyst price targets and the full financials are in the terminal.
Who Eli Lilly and buys from, sells to and competes with From our value chain
Eli Lilly and in the news
No desk stories on LLY yet. When we write about it, the story leads this list.
- HeadlineHere's How Much Eli Lilly Stock Is Expected to Move After EarningsInvestopedia · October 28, 2026 at 6:22 AM ET
- Headline$10,000 Invested in Eli Lilly 5 Years Ago Would Be Worth This Much TodayThe Motley Fool · October 27, 2026 at 7:08 PM ET
- HeadlineEli Lilly international business chief Jonsson to retire; Yuffa to head global markets unitReuters · October 27, 2026 at 4:38 PM ET
- HeadlineBuy, Sell or Hold LLY Stock? Key Factors to Watch Ahead of Q3 EarningsZacks Investment Research · October 27, 2026 at 9:56 AM ET
- HeadlineLilly declares fourth-quarter 2026 dividendPRNewsWire · October 26, 2026 at 11:19 AM ET
- HeadlineLLY vs. MRK: Which Stock Offers the More Compelling Investment Case?Zacks Investment Research · October 26, 2026 at 10:31 AM ET
- HeadlineLilly (LLY) Q3 Earnings Preview: What You Should Know Beyond the Headline EstimatesZacks Investment Research · October 26, 2026 at 10:16 AM ET
- HeadlineEli Lilly (LLY) Price Forecast: Breakout Strengthens Ahead of EarningsFXEmpire · October 22, 2026 at 4:59 PM ET
Earnings
Next report: Thursday, Oct 29, 2026, before the open.
Congress trades in LLY
5 purchases and 3 sales in the latest 8 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 4, 2026 | Oct 9, 2026 |
| John BoozmanSenate · R-Arkansas | Sale | $1,001 - $15,000 | Nov 21, 2025 | Aug 24, 2026 |
| Michael RulliHouse · R-Ohio | Purchase | $1,001 - $15,000 | Jan 2, 2026 | Aug 10, 2026 |
| Tommy TubervilleSenate · R-Alabama | Sale | $15,001 - $50,000 | Apr 15, 2025 | Aug 5, 2026 |
| Dan NewhouseHouse · R-Washington | Sale | $1,001 - $15,000 | Jul 10, 2026 | Jul 20, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Jun 2, 2026 | Jul 8, 2026 |
| Gilbert CisnerosHouse · D-California | Purchase | $50,001 - $100,000 | Jun 10, 2026 | Jul 3, 2026 |
| Byron DonaldsHouse · R-Florida | Purchase | $1,001 - $15,000 | Apr 2, 2026 | May 14, 2026 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Eli Lilly and
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 50,000
- Headquarters
- Indianapolis, Indiana
- Website
- lilly.com
- Listed
- Jun 1, 1972
More drug manufacturers - general stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.